Skip to content

Evommune EVMN Balance Sheet Statement

FY'25FY'24FY'23
$2.72M+1,217%$206.89K-44.7%$374.44K
$382.3K
$1.71M
$5.19M+81.5%$2.86M
$37.38K-24.6%$49.56K
$818.14K0.0%$818.14K
$161.71K
$3.92M-9.1%$4.31M
$9.11M+27.0%$7.17M
$668.22K-39.4%$1.1M
$154.96K
$154.96K
$5.75M+10.5%$5.2M
$140.47K
$1.82M-12.9%$2.09M
$7.57M+3.8%$7.29M
220M0.0%220M
-$6.98M+8.9%-$7.66M
$1.54M+1,400%-$118.58K-558%$25.88K
$9.11M+27.0%$7.17M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Evommune 's total assets?
Evommune (EVMN) holds $7.2M in total assets.
How much debt does Evommune have?
Evommune carries $2.0M in total debt against -$4.5M of shareholders' equity, a debt-to-equity ratio of 1.36.
How much cash does Evommune have?
Evommune holds $1.1M in cash and equivalents.
Can Evommune cover its short-term obligations?
Its current ratio is 1.20 — current assets exceed current liabilities.
Where does Evommune 's balance sheet data come from?
Every line is extracted from Evommune 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.